)
)
)
Professor Rachel Batterham
Professor Rachel Batterham is Senior Vice President, Medical Innovation and External Engagement for Global Cardiometabolic Health at Eli Lilly and Company. She is internationally recognised for pioneering research showing how gut hormones can be used to treat obesity, and brings decades of experience caring for people living with obesity.
Before joining Lilly, Rachel was Professor of Obesity, Diabetes and Endocrinology at University College London (UCL) and an Honorary Consultant at University College London Hospitals (UCLH), where she founded and led the UCL Centre for Obesity Research and served as the Royal College of Physicians’ Special Adviser on Obesity. She retains an Honorary Professorship at UCL and an Honorary Consultant position at UCLH.
In 2022, Rachel was awarded an OBE by the late Queen Elizabeth II for services to people with obesity, recognising a 25-year career spanning basic science, Phase 1–4 clinical trials, and public policy. In 2017, she founded the Obesity Empowerment Network UK, a charity that ensures people affected by obesity help shape policy, research, and services. At Lilly, she partners with clinicians, advocacy groups, and health systems to help more people access effective, compassionate care.